Subscription of warrants
Nykode Therapeutics ASA (NYKD) · publisert 3. desember 2021 kl. 16:49 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Agnete Brunsvik Fredriksen | Chief Innovation & Strategy Officer | Annet Emisjon/tegning | 1 422 900 | 0 NOK | 3. desember 2021 | NO0010714785 | Outside of trading venue |
| Agnete Brunsvik Fredriksen | Chief Innovation & Strategy Officer | Annet Emisjon/tegning | 1 422 900 | 0 NOK | 3. desember 2021 | NO0010714785 | Outside of trading venue |
| Anders Tuv | Styreleder | Annet Emisjon/tegning | 800 000 | 0 NOK | 3. desember 2021 | NO0010714785 | Outside of trading venue |
| Anders Tuv | Styreleder | Annet Emisjon/tegning | 800 000 | 0 NOK | 3. desember 2021 | NO0010714785 | Outside of trading venue |
Vedlegg
- Attachment 211203.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, December 3, 2021 - Reference is made to the Extraordinary General Meeting (EGM) in Vaccibody AS held on November 30, 2021, where an extension of the expiry date for certain warrants held by primary insiders Agnete B. Fredriksen and Anders Tuv was resolved. The extension will be made through the termination of existing warrants and the issuance of the same number of new warrants with the new expiry date. Agnete B. Fredriksen and Anders Tuv have today subscribed for the warrants on the terms resolved by the EGM.
Please see further details in attached document.